Julia Foldi

1.9k citations

50 papers · 1.3k indexed · h-index 14

Impact in

Agronomy and Crop Science top 2%
- Reproductive Physiology in Livestock
- Ruminant Nutrition and Digestive Physiology
Immunology top 5%
- Immune cells in cancer
- Immune Response and Inflammation
- Immune Cell Function and Interaction
- Reproductive System and Pregnancy

Papers in ⓘ

Cancer Research 24
- Breast Cancer Treatment Studies 13
- Cancer Genomics and Diagnostics 11
Oncology 24
- HER2/EGFR in Cancer Research 9
- Cancer Treatment and Pharmacology 8
- Cancer Immunotherapy and Biomarkers 5
- Cancer Cells and Metastasis 4

Co-authors: Xiaoyu Hu (4 shared papers)Lionel B. Ivashkiv (4 shared papers)Allen Chung (3 shared papers)Margit Kulcsár (2 shared papers)Haixia Xu (2 shared papers)Jan Kitajewski (2 shared papers)Jimmy Zhu (2 shared papers)Yue‐Ming Li (2 shared papers)
Journals: Journal of Clinical Oncology (6 papers)Clinical Cancer Research (4 papers)Cancer Research (4 papers)JNCI Journal of the National Cancer Institute (3 papers)ESMO Open (3 papers)
Partner nations: United States Hungary France

In The Last Decade

Julia Foldi

41 papers receiving 1.3k citations

Peers

Countries citing papers authored by Julia Foldi

Since Specialization

Citations

This map shows the geographic impact of Julia Foldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Foldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Foldi more than expected).

Fields of papers citing papers by Julia Foldi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Foldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Foldi. The network helps show where Julia Foldi may publish in the future.

Co-authors

The 25 scholars most cited alongside Julia Foldi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Julia Foldi Line = papers co-authored together Julia Foldi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Notch–RBP-J signaling regulates the transcription factor IRF8 to promote inflammatory macrophage polarization Nature Immunology ·Haixia Xu, Jimmy Zhu, Sinéad M. Smith, Julia Foldi, Baohong Zhao, Allen Chung, Hasina H. Outtz, Jan Kitajewski, Chao Shi, Silvio Weber, Paul Säftig, Yue‐Ming Li, Keiko Ozato, Carl Blobel, Lionel B. Ivashkiv, Xiaoyu Hu	2012	353
2	Integrated Regulation of Toll-like Receptor Responses by Notch and Interferon-γ Pathways Immunity ·Xiaoyu Hu, Allen Chung, Indira Wu, Julia Foldi, Janice Chen, Jong Dae Ji, Tomoko Tateya, Young Jun Kang, Jiahuai Han, Manfred Gessler, Ryoichiro Kageyama, Lionel B. Ivashkiv	2008	213
3	Bacterial complications of postpartum uterine involution in cattle Animal Reproduction Science ·Julia Foldi, Margit Kulcsár, Anna Pécsi, B. Huyghe, C. de, J.A.C.M. Lohuis, Peter Cox, Gy. Huszenicza	2006	206
4	Autoamplification of Notch Signaling in Macrophages by TLR-Induced and RBP-J–Dependent Induction of Jagged1 The Journal of Immunology ·Julia Foldi, Allen Chung, Haixia Xu, Jimmy Zhu, Hasina H. Outtz, Jan Kitajewski, Yue‐Ming Li, Xiaoyu Hu, Lionel B. Ivashkiv	2010	105
5	Periparturient insulin secretion and whole-body insulin responsiveness in dairy cows showing various forms of ketone pattern with or without puerperal metritis Domestic Animal Endocrinology ·M. Kerestes, V. Faigl, Margit Kulcsár, Orsolya Balogh, Julia Foldi, Hedvig Fébel, Yves Chilliard, G. Huszenicza	2009	90
6	Changing frameworks in treatment sequencing of triple-negative and HER2-positive, early-stage breast cancers The Lancet Oncology ·Lajos Pusztai, Julia Foldi, Arjun Dhawan, Michael P. DiGiovanna, Eleftherios P. Mamounas	2019	57
7	RBP-J is required for M2 macrophage polarization in response to chitin and mediates expression of a subset of M2 genes Protein & Cell ·Julia Foldi, Yingli Shang, Baohong Zhao, Lionel B. Ivashkiv, Xiaoyu Hu	2016	40
8	Cytomegalovirus Infection after CD34+-Selected Hematopoietic Cell Transplantation Biology of Blood and Marrow Transplantation ·Yao-Ting Huang, Dionysios Neofytos, Julia Foldi, Seong-Jin Kim, Molly Maloy, Dick Chung, Hugo Castro‐Malaspina, Sergio Giralt, Esperanza B. Papadopoulos, Miguel‐Angel Perales, Ann A. Jakubowski, Genovefa A. Papanicolaou	2016	28
9	Defining Risk of Late Recurrence in Early-Stage Estrogen Receptor–Positive Breast Cancer: Clinical Versus Molecular Tools Journal of Clinical Oncology ·Julia Foldi, Tess A. O’Meara, Michał Marczyk, Tara Sanft, Andrea Silber, Lajos Pusztai	2019	20
10	HIV-Infected Children Have Elevated Levels of PD-1+ Memory CD4 T Cells With Low Proliferative Capacity and High Inflammatory Cytokine Effector Functions The Journal of Infectious Diseases ·Julia Foldi, Lina Kozhaya, Bret McCarty, Mussa Mwamzuka, Fatma Marshed, Tiina Ilmet, Max Kilberg, Adam Kravietz, Aabid Ahmed, William Borkowsky, Derya Unutmaz, Alka Khaitan	2017	20
11	A precision medicine approach to metabolic therapy for breast cancer in mice Communications Biology ·Ngozi D. Akingbesote, Aaron D. Norman, Wanling Zhu, Alexandra A. Halberstam, Xinyi Zhang, Julia Foldi, Maryam B. Lustberg, Rachel J. Perry	2022	15
12	Single-arm, neoadjuvant, phase II trial of pertuzumab and trastuzumab administered concomitantly with weekly paclitaxel followed by 5-fluoruracil, epirubicin, and cyclophosphamide (FEC) for stage I–III HER2-positive breast cancer Breast Cancer Research and Treatment ·Julia Foldi, Sarah S. Mougalian, Andrea Silber, Donald R. Lannin, Brigid K. Killelea, Anees B. Chagpar, Nina Horowitz, Courtney Frederick, Lawrence Rispoli, Trisha Burrello, Maysa Abu‐Khalaf, Kert D. Sabbath, Tara Sanft, Debra Brandt, Erin Hofstatter, Christos Hatzis, Michael P. DiGiovanna, Lajos Pusztai	2018	14
13	Clinical Outcomes and Immune Markers by Race in a Phase I/II Clinical Trial of Durvalumab Concomitant with Neoadjuvant Chemotherapy in Early-Stage TNBC Clinical Cancer Research ·Julia Foldi, Adriana Kahn, Andrea Silber, Tao Qing, Emily Reisenbichler, Neal Fischbach, Justin Persico, Kerin B. Adelson, Anamika Katoch, Anees B. Chagpar, Tristen Park, Adam Blanchard, Kim Blenman, David L. Rimm, Lajos Pusztai	2022	13
14	Molecular differences between younger versus older ER-positive and HER2-negative breast cancers npj Breast Cancer ·Tao Qing, Thomas Karn, Mariya Rozenblit, Julia Foldi, Michał Marczyk, Naing Lin Shan, Kim Blenman, Uwe Holtrich, Kevin Kalinsky, Funda Meric‐Bernstam, Lajos Pusztai	2022	13
15	A phase 1 dose-escalation and expansion study of an intratumorally administered dual STING agonist (ONM-501) alone and in combination with cemiplimab in patients with advanced solid tumors and lymphomas. Journal of Clinical Oncology ·Julia Foldi, Sarina A. Piha‐Paul, Liza C. Villaruz, Heather L. McArthur, Madeline Olson, Euodia Jonathan, Brian Ostrander, Kartik Krishnan, Jason J. Luke	2024	11
16	Optimal Management for Residual Disease Following Neoadjuvant Systemic Therapy Current Treatment Options in Oncology ·Julia Foldi, Mariya Rozenblit, Tristen S. Park, Christin A. Knowlton, Mehra Golshan, Meena S. Moran, Lajos Pusztai	2021	11
17	Pharmacology and pharmacokinetics of elacestrant Cancer Chemotherapy and Pharmacology ·Jan H. Beumer, Julia Foldi	2023	10
18	CDK4/6 inhibitors: The Devil is in the Detail Current Oncology Reports ·Tara Magge, Sneha Rajendran, Adam Brufsky, Julia Foldi	2024	10
19	Cytomegalovirus resistance in CD34⁺‐selected hematopoietic cell transplant recipients Transplant Infectious Disease ·Seong-Jin Kim, Yao‐Ting Huang, Julia Foldi, Yeon Joo Lee, Molly Maloy, Sergio Giralt, Ann A. Jakubowski, Genovefa A. Papanicolaou	2018	10
20	Outcomes with trastuzumab deruxtecan (T-DXd) by HER2 status and line of treatment in a large real-world database of patients with metastatic breast cancer. Journal of Clinical Oncology ·Paolo Tarantino, Do Kyeong Lee, Julia Foldi, Pamela R. Soulos, Cary P. Gross, Thomas Grinda, Eric P. Winer, Nancy U. Lin, Ian E. Krop, Sara M. Tolaney, Maryam B. Lustberg, Sarah Sammons	2024	9

About Julia Foldi

Julia Foldi is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Virology and Immunology, having authored 50 papers that have together received 1.3k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (13 papers), Advanced Breast Cancer Therapies (13 papers), Cancer Genomics and Diagnostics (11 papers), HER2/EGFR in Cancer Research (9 papers), Cancer Treatment and Pharmacology (8 papers), Cancer Immunotherapy and Biomarkers (5 papers), Cancer Cells and Metastasis (4 papers) and Immune Cell Function and Interaction (4 papers). The work is most often cited by research in Agronomy and Crop Science (282 citations), Immunology (520 citations), Cancer Research (256 citations), Small Animals (79 citations) and Oncology (281 citations). Julia Foldi has collaborated with scholars based in United States, Hungary and France. Frequent co-authors include Xiaoyu Hu, Lionel B. Ivashkiv, Allen Chung, Margit Kulcsár, Haixia Xu, Jan Kitajewski, Jimmy Zhu, Yue‐Ming Li, Baohong Zhao and J.A.C.M. Lohuis. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Cancer Research, JNCI Journal of the National Cancer Institute and ESMO Open.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact